Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression
Clarissa D. Staton, Jazmine D. W. Yaeger, Delan Khalid, et al.
Neuropharmacology (2018) Vol. 143, pp. 79-94
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Understanding the Biological Relationship between Migraine and Depression
Adrián Viudez‐Martínez, Abraham B. Torregrosa, Francisco Navarrete, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 163-163
Open Access | Times Cited: 9
Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells
George Anderson, Moses Rodriguez, Rüssel J. Reiter
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5500-5500
Open Access | Times Cited: 73
Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy
Cliff H. Summers, Jazmine D. W. Yaeger, Clarissa D. Staton, et al.
Brain Research (2018) Vol. 1731, pp. 146085-146085
Open Access | Times Cited: 59
Linking peripheral IL-6, IL-1β and hypocretin-1 with cognitive impairment from major depression
Kangyu Jin, Jing Lü, Zhebin Yu, et al.
Journal of Affective Disorders (2020) Vol. 277, pp. 204-211
Closed Access | Times Cited: 54
Lateral hypothalamus orexinergic inputs to lateral habenula modulate maladaptation after social defeat stress
Dan Wang, Ao Li, Keyi Dong, et al.
Neurobiology of Stress (2021) Vol. 14, pp. 100298-100298
Open Access | Times Cited: 46
Anxiety and Depression: What Do We Know of Neuropeptides?
Ida Kupcová, Ľuboš Danišovič, Ivan Grgac, et al.
Behavioral Sciences (2022) Vol. 12, Iss. 8, pp. 262-262
Open Access | Times Cited: 36
Sleep-wake and arousal dysfunctions in post-traumatic stress disorder: Role of orexin systems
Gary B. Kaplan, Gabrielle A. Lakis, Hryhoriy Zhoba
Brain Research Bulletin (2022) Vol. 186, pp. 106-122
Closed Access | Times Cited: 32
Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone
Martin A. Katzman, Matthew P. Katzman
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 150-150
Open Access | Times Cited: 30
Resilience to the effects of social stress on vulnerability to developing drug addiction
Claudia Calpe-López, M. Ángeles Martínez-Caballero, María Pilar García-Pardo, et al.
World Journal of Psychiatry (2022) Vol. 12, Iss. 1, pp. 24-58
Open Access | Times Cited: 23
Orexin 1 Receptor Antagonism in the Basolateral Amygdala Shifts the Balance From Pro- to Antistress Signaling and Behavior
Jazmine D. W. Yaeger, Kevin T. Krupp, Benjamin Jacobs, et al.
Biological Psychiatry (2022) Vol. 91, Iss. 9, pp. 841-852
Open Access | Times Cited: 22
Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents
Octavian Vasiliu
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
Contextual generalization of social stress learning is modulated by orexin receptors in basolateral amygdala
Jazmine D. W. Yaeger, Kevin T. Krupp, Tangi R. Summers, et al.
Neuropharmacology (2022) Vol. 215, pp. 109168-109168
Open Access | Times Cited: 17
Orexin Receptor Antagonists in the Treatment of Depression: A Leading Article Summarising Pre-clinical and Clinical Studies
Harry Fagan, Edward G. Jones, David S. Baldwin
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 1-12
Closed Access | Times Cited: 17
Ecological validity of social defeat stressors in mouse models of vulnerability and resilience
David M. Lyons, Sarah Ayash, Alan F. Schatzberg, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 145, pp. 105032-105032
Closed Access | Times Cited: 10
Hunger Potentiates the Habenular Winner Pathway for Social Conflict by Orexin-Promoted Biased Alternative Splicing of the AMPA Receptor Gene
Haruna Nakajo, Ming-Yi Chou, Masae Kinoshita, et al.
Cell Reports (2020) Vol. 31, Iss. 12, pp. 107790-107790
Open Access | Times Cited: 23
Evolution of stress responses refine mechanisms of social rank
Wayne J. Korzan, Cliff H. Summers
Neurobiology of Stress (2021) Vol. 14, pp. 100328-100328
Open Access | Times Cited: 19
Chronic orexin-1 receptor blockage attenuates depressive behaviors and provokes PSD-95 expression in a rat model of depression
Batoul Mirbolouk, Kambiz Rohampour, Mohammad Rostampour, et al.
Behavioural Brain Research (2022) Vol. 437, pp. 114123-114123
Closed Access | Times Cited: 13
Dysregulation of striatal dopamine D2/D3 receptor-mediated by hypocretin induces depressive behaviors in rats
Bing Chen, Jiangang Xu, Simiao Chen, et al.
Journal of Affective Disorders (2023) Vol. 325, pp. 256-263
Closed Access | Times Cited: 7
Resilience and its correlates in patients with narcolepsy type 1
Alessandra D’Alterio, Marco Menchetti, Corrado Zenesini, et al.
Journal of Clinical Sleep Medicine (2023) Vol. 19, Iss. 4, pp. 719-726
Open Access | Times Cited: 7
Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety
Wojciech Ziemichód, Antonina Kurowska, Karolina Grabowska, et al.
Molecules (2023) Vol. 28, Iss. 8, pp. 3575-3575
Open Access | Times Cited: 7
Orexin/hypocretin receptor gene (HCRTR1) variation is associated with aggressive behaviour
Jaanus Harro, Kariina Laas, Diva Eensoo, et al.
Neuropharmacology (2019) Vol. 156, pp. 107527-107527
Open Access | Times Cited: 22
Involvement of orexin-A in the regulation of neuronal activity and emotional behaviors in central amygdala in rats
Yi-Peng Pan, Cui Liu, Meifang Liu, et al.
Neuropeptides (2020) Vol. 80, pp. 102019-102019
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top